AMISULPRIDE
Watsons Health

AMISULPRIDE

Amisulpride tablets are used in the treatment of schizophrenic disorders, in which there are positive symptoms such as delusions and hallucinations as well as negative symptoms like emotional and social withdrawal.

Amisulpride is used to treat acute psychosis.

Do not give Amisulpride to people with the following conditions:

  • Phaeochromocytoma
  • Concomitant prolactin-dependent tumors (such as pituitary gland prolactinomas or breast cancer)
  • Pre-pubertal children
  • Combination with levodopa

Amisulpride may have the following side effects:

  • Insomnia
  • Anxiety
  • Agitation
  • Drowsiness
  • Weight gain
  • Acute dystonia
  • Parkinsonism
  • Hyperglycaemia
  • Breast pain
  • Neuroleptic malignant syndrome

Take extra caution in patients with the following medical conditions:

  • Patientswith a history of epilepsy
  • Parkinson’s disease
  • Cardiovascular disease
  • Renal impairment
  • Elderly
  • Pregnancy
  • Lactation

Interactions

Amisulpride may interact with the following medicines:

  • Thioridazine
  • Halofantrine
  • Erythromycin
  • Clonidine
  • Guanfacine
  • Digoxin
  • Benzodiazepines
  • Levodopa

Symptoms of overdose may include the following:

  • Generalized convulsions
  • Coma
  • Motor restlessness
  • Tachycardia
  • Slight prolongation of the QT intervalon ECG
  • Drowsiness
  • Sedation
  • Hypotension

Seek medical help immediately

Available Brands:

  • Amiabel
  • Solian

Related Articles

DTP-HIB Vaccine

DTP-HIB vaccine is a combined vaccine of adsorbed diphtheria, tetanus toxoid and acellular pertussis and of Haemophilus influenzae type b conjugate vaccines. It is a [...]

Tenecteplase

Tenecteplase is a tissue-type plasminogen activator (tPA), a biosynthetic form of human enzyme that is a fibrin-specific thrombolytic agent, converting plasminogen to [...]

Selexipag

Selexipag is a selective non-prostanoid agonist of prostacyclin (IP) receptor, that stimulates the release of prostacyclin, which is responsible to induce [...]